The United States will share with other countries its stock of up to 60 million doses of AstraZeneca Plc's coronavirus vaccine as they become available over the next few months, the White House said Monday."We do not need to use AstraZeneca in our fight against COVID over the next few months," Press Secretary Jen Psaki said at a press conference, noting that the British company's vaccine has yet to be authorized by the U.S. drug regulator, while three other vaccines have already been available in large quantities in the country.She did not name any specific countries that are set to receive…READ FULL ARTICLE